About Us Kolon TissueGene, Inc. (KTG) is a clinical‑stage cell therapy company headquartered in Rockville, Maryland. We are dedicated to developing transformative biological therapies for patients suffering from degenerative joint diseases—conditions that affect tens of millions of people worldwide